Intellia Therapeutics, Inc. (NTLA)
USD 12.02
(-8.45%)
USD 12.02
(-8.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -394.08 Million | -333.28 Million | -225.03 Million | -49.91 Million | -103.24 Million | -61.25 Million |
| Net Income | -481.19 Million | -474.18 Million | -267.89 Million | -134.23 Million | -99.53 Million | -85.34 Million |
| Depreciation & Amortization | 8.97 Million | 7.57 Million | 6.89 Million | 6.31 Million | 5.58 Million | 4.46 Million |
| Deferred income taxes | -10.19 Million | - | 8.92 Million | - | - | - |
| Stock-based compensation | 134.05 Million | 91.4 Million | 47 Million | 19.9 Million | 15.09 Million | 17.04 Million |
| Change in working capital | -52.45 Million | -53.87 Million | -22.9 Million | 57.53 Million | -20.66 Million | 3.17 Million |
| Other non-cash items | 6.72 Million | 95.8 Million | 2.93 Million | 573 Thousand | -3.72 Million | -601 Thousand |
| Investing Cash Flow | -31.34 Million | 160.3 Million | -550.77 Million | -214.48 Million | 25.17 Million | -260.78 Million |
| Investments in PPE | -13.98 Million | -58.39 Million | -12.75 Million | -3.58 Million | -6.79 Million | -6.35 Million |
| Acquisitions | 17.36 Million | -44.68 Million | -3 Million | 210.9 Million | -31.97 Million | 131 Thousand |
| Investment purchases | -904.46 Million | -429.03 Million | -1.02 Billion | -473.7 Million | -297.03 Million | -254.55 Million |
| Sales/Maturities of investments | 887.1 Million | 647.58 Million | 485.59 Million | 262.8 Million | 329 Million | - |
| Other Investing Activities | -17.36 Million | 44.83 Million | -538.02 Million | -210.9 Million | 31.97 Million | 131 Thousand |
| Financing Cash Flow | 130.32 Million | 582.95 Million | 736.68 Million | 371.77 Million | 76.43 Million | 40.21 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 119.79 Million | 565.78 Million | 736.68 Million | 358.64 Million | 72.25 Million | 28.97 Million |
| Other Financing Activities | 10.52 Million | 17.16 Million | 736.68 Million | 13.13 Million | 4.17 Million | 11.24 Million |
| Accounts receivables | -32.68 Million | -1.73 Million | 99 Thousand | 2.49 Million | 2.92 Million | 2.92 Million |
| Accounts payables | 2.52 Million | -4.58 Million | 529 Thousand | 5.06 Million | 1.88 Million | 232 Thousand |
| Inventory | -19.5 Million | - | 7.82 Million | 4.86 Million | 1.65 Million | 3.95 Million |
| Other working capital | -2.77 Million | -47.55 Million | -31.35 Million | 45.12 Million | -27.12 Million | -3.93 Million |
| Cash at beginning of period | 535.46 Million | 125.48 Million | 164.6 Million | 57.22 Million | 58.85 Million | 340.67 Million |
| Cash at end of period | 240.35 Million | 535.46 Million | 125.48 Million | 164.6 Million | 57.22 Million | 58.85 Million |
| Capital Expenditure | -13.98 Million | -58.39 Million | -12.75 Million | -3.58 Million | -6.79 Million | -6.35 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -295.11 Million | 409.97 Million | -39.12 Million | 107.38 Million | -1.63 Million | -281.82 Million |
| Free Cash Flow | -408.07 Million | -391.67 Million | -237.78 Million | -53.49 Million | -110.03 Million | -67.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -146.97 Million | -107.43 Million | -132.16 Million | -481.19 Million | -122.22 Million | -123.68 Million |
| Depreciation & Amortization | 2.59 Million | 2.51 Million | 2.46 Million | 8.97 Million | 2.29 Million | 2.17 Million |
| Deferred income taxes | - | - | 7.15 Million | -10.19 Million | -4.07 Million | -3.08 Million |
| Stock-based compensation | 40.86 Million | 34.17 Million | 35.04 Million | 134.05 Million | 35.35 Million | 36.4 Million |
| Change in working capital | 29.62 Million | -29.72 Million | 3.11 Million | -52.45 Million | -13.69 Million | -4.97 Million |
| Other non-cash items | 32.31 Million | 13.41 Million | -8.66 Million | 6.72 Million | 968 Thousand | 2.84 Million |
| Investing Cash Flow | -24.19 Million | 5.9 Million | 45.93 Million | -31.34 Million | 79.5 Million | -34.53 Million |
| Investments in PPE | -1.01 Million | -2.5 Million | -1.52 Million | -13.98 Million | -4.33 Million | -4.3 Million |
| Acquisitions | - | - | -47.45 Million | 17.36 Million | -83.83 Million | 30.23 Million |
| Investment purchases | -300.81 Million | -259.55 Million | -149.77 Million | -904.46 Million | -129.37 Million | -243.28 Million |
| Sales/Maturities of investments | 277.63 Million | 267.96 Million | 197.23 Million | 887.1 Million | 213.2 Million | 213.04 Million |
| Other Investing Activities | -23.17 Million | 8.4 Million | 47.45 Million | -17.36 Million | 83.83 Million | -30.23 Million |
| Financing Cash Flow | 41.24 Million | 59.99 Million | 106.48 Million | 130.32 Million | 19.1 Million | 2.51 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 41.24 Million | 59.99 Million | 103.61 Million | 119.79 Million | 14.71 Million | 2.51 Million |
| Other Financing Activities | 41.24 Million | 59.99 Million | 2.87 Million | 10.52 Million | 4.38 Million | 2.51 Million |
| Accounts receivables | 24.09 Million | 29 Thousand | -29.96 Million | -32.68 Million | -1.43 Million | -151 Thousand |
| Accounts payables | 5.34 Million | 5.56 Million | 3.94 Million | 2.52 Million | -7.7 Million | 5.11 Million |
| Inventory | - | - | -8.64 Million | -19.5 Million | 4.23 Million | 4.41 Million |
| Other working capital | 178 Thousand | -35.32 Million | 37.78 Million | -2.77 Million | -8.78 Million | -14.35 Million |
| Cash at beginning of period | 171.97 Million | 226.74 Million | 180.98 Million | 535.46 Million | 183.76 Million | 306.1 Million |
| Cash at end of period | 130.84 Million | 171.97 Million | 240.35 Million | 240.35 Million | 180.98 Million | 183.76 Million |
| Capital Expenditure | -1.01 Million | -2.5 Million | -1.52 Million | -13.98 Million | -4.33 Million | -4.3 Million |
| Effect of forex changes on cash | - | - | -122.39 Million | - | - | 122.39 Million |
| Net cash flow / Change in cash | -41.13 Million | -54.76 Million | 59.36 Million | -295.11 Million | -2.77 Million | -122.34 Million |
| Free Cash Flow | -59.19 Million | -123.16 Million | -94.57 Million | -408.07 Million | -105.71 Million | -94.62 Million |
6698
VPHIF
VNUE
E4C
ICE
VSBGF